Kanjinti is a targeted antibody treatment biosimilar to Herceptin. It contains trastuzumab, which treats HER2-positive breast cancer and metastatic stomach cancer. It works by blocking the HER2 receptors on cancer cells, stopping their growth and signaling the immune system to destroy them. It is administered via intravenous infusion.
| Kanjinti | Brand | 420mg | 1 Vial | $1,800.00 |
If you are interested in this product , please contact our customer service staff below:
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Discover how to manage dryness and discomfort while maintaining vaginal health through simple, effective strategies and affordable care.
For many living with severe asthma, daily life can feel like a balancing act between managing symptoms and coping with the side effects of treatment. Tezspire (tezepelumab) is a newer biologic medication approved for add-on
Starting a new health journey can feel like a big, positive step forward. But sometimes, our bodies react in ways we don’t expect, leading to moments that can be a little uncomfortable or even embarrassing.
